Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

Molecular Cell

Volumn 7, Issue 2, 2001, Pages 249-262

  Garcia Higuera, Irene ^a   Taniguchi, Toshiyasu ^a   Ganesan, Shridar ^b   Meyn, M Stephen ^c   Timmers, Cynthia ^d   Hejna, James ^d   Grompe, Markus ^d   D'Andrea, Alan D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; GENE PRODUCT; MITOMYCIN C; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG SENSITIVITY; FANCONI ANEMIA; HUMAN; HUMAN CELL; IONIZING RADIATION; MOLECULAR CLONING; PHENOTYPE; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 0035105291     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00173-3     Document Type: Article

References (68)

1. Fanconi's anemia and malignancies
2. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
3. The RNA polymerase I transcription factor xUBF contains 5 tandemly repeated HMG homology boxes
4. Studies of malformation syndromes of man XLVII: Disappearance of spermatogonia in the Fanconi anemia syndrome
5. G2 chromosomal radiosenitivity in Fanconi's anamia
6. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups
7. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia
8. The ubiquitin-proteasome proteolytic pathway
9. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks
10. Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
11. Deubiquitinating enzymes: A new class of biological regulators
12. The Fanconi anaemia group G gene is identical with human XRCC9
13. Isolation of a cDNA representing the Fanconi anemia complementation group E gene
14. The Fanconi anemia complementation gene FANCF encodes a novel protein with homology to ROM
15. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
16. Abnormal response to DNA crosslinking agents of Fanconi anemia fibroblasts can be corrected by transfection with normal human DNA
17. Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene
18. Effects on ionizing radiation on cells from Fanconi's anemia patients
19. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining
20. Positional cloning of the Fanconi anaemia group A gene
21. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
22. The Fanconi anemia proteins, FANCA and FANCG, stabilize each other and promote the nuclear accumulation of the FA complex
23. Radiosensitivity in Fanconi anemia: Application to the conditioning regimen for bone marrow transplantation
24. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase
25. RING finger proteins: Mediators of ubiquitin ligase activity
26. Evidence for at least eight Fanconi anemia genes
27. Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A
28. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment
29. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF (Met30)-mediated inactivation of the transcription factor Met4
30. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes
31. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene
32. The carboxy terminal region of the Fanconi anemia protein, FANCG, is required for functional activity
33. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells
34. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation
35. The Fanconi anemia protein, FAC, binds to the cyclin-dependent kinase, cdc2
36. The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex
37. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
38. Accelerated telomere shortening and telomerase activation in Fanconi's anemia
39. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
40. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
41. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA
42. Synaptonemal complex antigen location and conservation
43. Brca1 controls homology-directed DNA repair
44. Identification of ubiquitinated histones 2A and 2B in Physarum polycephalum
45. Functional activity of the Fanconi anemia protein, FAA, requires FAC binding and nuclear localization
46. A drying-down technique for the spreading of mammalian meiocytes from the male and female germline
47. ll250, a mediator of activation of gene expression in Drosophila
48. Rad6-dependent ubiquitination of histone H2B in yeast
49. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site
50. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
51. Association of BRCA1 with Rad51 in mitotic and meiotic cells
52. Genetic analysis of BRCA1 function in a defined tumor cell line
53. Monoubiquitin carries a novel internalization signal that is appended to activated receptors
54. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia
55. Cloning of cDNAs for Fanconi's anaemia by functional complementation
56. Elevated homologous recombination activity in Fanconi anemia fibroblasts
57. Positional cloning of a novel Fanconi anemia gene, FANCD2
58. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier
59. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
60. The levels of ubiquitinated histone H2A are highly upregulated in transformed human cells: Partial colocalization of uH2A clusters and PCNA/cyclin foci in a fraction of cells in S-phase
61. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
62. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
63. Microcell mediated chromosome transfer maps the Fanconi anemia group D gene to chromosome 3p
64. Independence of R/M/N focus formation and the presence of intact BRCA1
65. The Fanconi anemia polypeptide FACC is localized to the cytoplasm
66. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
67. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response
68. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres